MAY 31: PROSTABLOG NZ: Here’s a question that doesn’t seem to have been addressed for a while – how come fewer Maori than non-Maori are registered as prostate cancer sufferers, yet the death rate among Maori is twice that of non-Maori? READ MORE>
MAY 31: NOT ALONE BLOG: Flomax (tamsulosin), a drug that is commonly used by men to treat their prostate problems, is linked to more than a double risk for serious complications following cataract surgery, indicates new study by Canadian scientists. READ MORE>
MAY 31: E-TV: Adult prostate stem or progenitor cells may acquire characteristics of self-renewing primitive foetal prostate cells during oncogenesis and aberrant activation of components of prostate stem cell pathways may contribute to the development of prostate tumours. READ MORE>
MAY 31: CANCER.COM: Some newer research reveals that green tea might help prevent the spread of prostate cancer. Specifically the phytochemicals found in green tea, called polyphenols attack the growth factors and protiens interupting the growth processes of tumors, resulting in preventing them from spreading to other organs of the body. READ MORE>
MAY 31: NEW PROSTATE CANCER INFO-LINK: Patients with metastatic castration-resistant prostate cancer can be safely treated with high-dose testosterone (at least in clinical trials using testosterone patches), and future studies should employ strategies to maximize testosterone serum levels. READ MORE>
MAY 31: NEW PROSTATE CANCER INFO-LINK: The future of prostate cancer detection may lie in complex assays systems that can test for several markers at the same time and use the accumulated data to assess prostate cancer risk. READ MORE>
MAY 31: PRESSEMITTEILUNG: A German molecular diagnostics company developing cancer detection products based on DNA methylation will report clinical data from its study validating the mPITX2 biomarker in a prognostic setting in prostate cancer. READ MORE>
MAY 30: PROSTABLOG NZ: The partner of a NZ man with advancing prostate cancer says the public health system can’t test him for bone deterioration for at least year. FULL STORY HERE>
MAY 29: NEW PROSTATE CANCER INFO-LINK: A US researcher has reviewed the strategic options for recurrent biopsy in men with one or more prior negative biopsies but continuing indications of risk of prostate cancer. Indications for repeat biopsy include “sustained or worsening of the findings that prompted the initial biopsy;” PSA velocity, PSA doubling times, and other PSA-derived data; and “the histology from the initial biopsy” (ie, high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation). READ MORE>
MAY 29: NEW PROSTATE CANCER INFO-LINK: Researchers have presented retrospective data on management of 77 patients treated with radical prostatectomy between 2003 and 2008 by one surgeon. READ MORE
MAY 29: NEW PROSTATE CANCER INFO-LINK: Researchers have reviewed a variety of prostate cancer prevention strategies, including use of 5α-reductase inhibitors, statins (a class of compounds used to reduce cholesterol), NSAIDs, selenium, vitamins E and D, lycopene, allium vegetables (garlic, scallions, onions, chives, and leeks), soy/isoflavones, and green tea polyphenols. READ MORE>
MAY 29: NEW PROSTATE CANCER INFO-LINK: Cryotherapy has a significant role to play in the evolution of focal therapy for prostate cancer – if we can learn to successfully identify those men who need and can be effectively and safely treated using focal therapy. READ MORE>
MAY 29: SCIENCE BLOG: A new blood test used in combination with a conventional prostate-specific antigen (PSA) screening sharply increases the accuracy of prostate cancer diagnosis, and could eliminate tens of thousands of unneeded, painful, and costly prostate biopsies annually, according to a study led by researchers at Dana-Farber Cancer Institute. READ MORE>
MAY 29: MIRROR.CO.UK: As many as 10,000 (UK) men a year are killed by prostate cancer, making it Britain’s most common – and deadly – male cancer. Now scientists believe they’ve found a drug – abiraterone – capable of treating this lethal form of the disease and shrinking tumours in up to three-quarters of cases. READ MORE>
MAY 28: NEW PROSTATE CANCER INFO-LINK: Analysis of 16,535 men showed that patients who received primary androgen deprivation therapy actually had a worse overall survival rate than patients who were observed. READ MORE>
MAY 28: NEW PROSTATE CANCER INFO-LINK: Researchers report they can identify the presence of prostate cancer cells in urine following prostate massage as a possible means to identify risk for prostate cancer. However, this is hardly the “non-invasive” method we most need to be able to identify risk for clinically significant as opposed to indolent prostate cancer! READ MORE>
MAY 28: NEW PROSTATE CANCER INFO-LINK: At what age would one need to start wearing amber glasses or avoiding blue-free light bulbs to lower one’s prostate cancer risk? READ MORE>
MAY 28: HULIQ NEWS: The majority of men who receive one of the standard treatments for localised prostate cancer – surgery or radiation therapy – have an excellent outcome. But for the small group whose prostate cancer returns, a new study offers insight as to why treatment isn’t effective. READ MORE>
MAY 28: URO TODAY: Prostate cryotherapy for localized prostate cancer is an evolving but viable therapeutic option. Long-term data are still needed to establish a definitive role for cryosurgery in prostate cancer treatment. READ MORE>
MAY 28: NEW JERSEY BUSINESS NEWS: Cougar Biotechnology, the developer of cancer medicines that Johnson & Johnson agreed to buy last week, said its lead experimental drug worked against prostate tumours in a company-sponsored study. READ MORE>
MAY 27: BIO-MEDICINE: High-grade prostatic intraepithelial neoplasia (HGPIN) carries a high predictive value for future diagnosis of prostate cancer. Research published in the open access journal BMC Urology has shown that 41.8% of patients whose extended core biopsy led to an initial diagnosis of HGPIN were subsequently diagnosed with prostate cancer. READ MORE>
MAY 27: PROSTABLOG NZ: Just when they thought they had second place at last, Rowing For Prostate had that honour snatched from them as they finally passed the women’s crew – only to see the eights sneak past. READ MORE>
MAY 27: DUNIYALIVE.COM: A new study in mice has suggested that restricting carbohydrates could slow the growth of prostate cancer tumours. READ MORE>
MAY 27: NEW PROSTATE CANCER INFO-LINK: New reports on HIFU (high-intensity focused ultrasound) treatment highlight the dangers of patients accepting new methods whose long-term effectiveness has yet to be proved. Mike Scott: “We expect many men to continue to elect HIFU as a treatment for prostate cancer. We expect many of these men to do well. We also expect a significant number to have significant problems and complications. As usual, caveat emptor!” READ MORE>
MAY 27: NEW PROSTATE CANCER INFO-LINK: We have a way to go before genetic testing is going to help us diagnose clincially significant prostate cancer with high accuracy. READ MORE>
MAY 27: NEW PROSTATE CANCER INFO-LINK: An article on the screening controversy in Oncology News International misinterprets the new American Urological Association guidance document. READ MORE>
MAY 27: URO TODAY: A study of cyclophosphamide (CP)-based chemotherapy used on 17 hormone therapy-resistant patients showed the treatment was well tolerated and almost without toxicity. Further advantages of low-dose CP were its convenient oral administration, dosing schedule, low cost, and low-toxicity profile. These attributes in combination with immuno-regulatory and anti-angiogenic potentials make CP also a prime candidate for combination with other treatment regimens. READ MORE>
MAY 26: STUFF: NZ Health and Disability Commissioner Ron Paterson has called for more robust systems to be implemented at Nelson Hospital after a man underwent unnecessary prostate surgery. The 67-year-old man underwent radical surgery in 2007 after he was diagnosed with prostate cancer by a locum senior pathologist. While the surgery was uneventful, the man experienced ongoing urinary incontinence and another pathologist reviewed the diagnosis and found no evidence of malignancy. READ MORE>
MAY 26: TALES FROM SERENITY NOW HOSPITAL: How some US doctors learn to perform digital examinations on patients – a bizarre tale: “The patient recieved 100 dollars per five rectals or 20 bucks each finger. Many of these patients smelled of alcohol, had no teeth, had mental illnesses, and were addicted to IV drugs…” READ MORE>
MAY 26: HEALTH CARE BLOG: A new study has shown that soy cereal, developed by a professor of food and nutrition, not only helps tackle obesity but it may also cut cancer risk. Soo-Yeun Lee, a professor of food science and nutrition from the University of Illinois has come up with a cinnamon-flavoured soy cereal that he claims can reduce the risk of prostate and breast cancer. READ MORE>
MAY 26: TOP CANCER NEWS: A cancer researcher says some metabolites indicate not only the presence of prostate cancer, but its aggressiveness. READ MORE
MAY 26: CAPITAL NEWS 9: The recent long-term studies of the effectiveness of prostate cancer screening were confusing, says one US general practitioner, while another says older men should get their PSA tested every year. READ MORE>
MAY 25: NEW PROSTATE CANCER INFO-LINK: A group of German researchers has developed a method to predict the duration of urinary incontinence after radical prostatectomy based on potential risk factors. READ MORE>
MAY 25: NEW PROSTATE CANCER INFO-LINK: There is some media buzz around publication of the results of a Phase I trial of Zyflamend, a commercially available herbal concoction. However, this information is not particularly new. READ MORE>
MAY 25: STATESMAN.COM: US researchers say they haven’t learned enough about HIFU (high-intensity focused ultrasound), which heats the prostate to destroy cancerous tissue yet to make judgments about it. And some have questioned the ethics of doctors being paid directly by a company for a procedure that must be performed in another country (ie, Mexico). READ MORE>
MAY 25: NEW PROSTATE CANCER INFO-LINK: Open radical prostatectomy is a less-invasive procedure with low morbidity providing excellent control of clinically localised prostate cancer, a new study has concluded. READ MORE>
MAY 24: GAPMINDER.COM: This video reviews the risk of getting diagnosed with, and the risk of dying from, prostate cancer in the world. The data is compiled by the International Agency for research on Cancer in Lyon, France. SEE VIDEO>
MAY 24: NEW PROSTATE CANCER INFO-LINK: A Canadian group has just added a little more to our knowledge about the role of neoadjuvant hormone therapy in association with radiotherapy after first-line radical prostatectomy. READ MORE>
MAY 24: NEWS SCIENCE: New research shows the G protein-coupled receptor OGR1 suppresses prostate cancer metastasis without affecting the primary tumor progression, suggesting that OGR1 is a novel metastasis suppressor gene for prostate cancer. READ MORE>
MAY 24: PROSTABLOG NZ: Rowing For Prostate just can’t seem to squeeze back into second place as the women’s crew of Pura Vida maintain a five mile gap on them in the Indian Ocean Rowing Race. READ MORE>
MAY 24: NEWS SCIENCE: A genetic marker associated with an earlier onset of prostate cancer in Caucasian men with a family history of prostate cancer has been identified by US researchers. A medical oncologist will present data on the finding at the annual meeting of the American Society of Clinical Oncology on Saturday. READ MORE>
MAY 24: NEWS SCIENCE: A cleaved form of galectin-3 may be a marker for prostate cancer progression, US researchers report in the April, 2009 , issue of The American Journal of Pathology. READ MORE>
MAY 24: TIMES OF THE INTERNET: US researchers have linked low oxygen levels in prostate tumors to cancer recurrence. Using a statistical model that accounted for such risk factors as tumor grade, prostate-specific antigen level and tumor size, researchers at the Fox Chase Cancer Center in Philadelphia found low oxygen — hypoxia — in the tumor before treatment to be a significant independent predictor of an increase in PSA levels. READ MORE>
MAY 24: SCIENCE DAILY: A phase I clinical trial of a herb-based therapeutic called Zyflamend has shown the therapy has minimal toxicity and no serious adverse events in men at high risk for developing prostate cancer. READ
MAY 23: SCIENCE BLOG: In studying the preventive effects of vitamin D, University of California researchers have proposed a new model of cancer development that hinges on a loss of cancer cells’ ability to stick together. The model, dubbed DINOMIT, differs substantially from the current model of cancer development, which suggests genetic mutations as the earliest driving forces behind cancer. READ MORE>
MAY 23: RENAL & UROLOGY NEWS: A study of low-income men found that most did not understand basic medical terms such as “erection”. Clinicians should speak colloquially when discussing prostate cancer with low-income men because most of them do not understand basic medical terms, according to a new study. READ MORE>
MAY 23: E-CANCER MEDICAL SCIENCE: While young men with prostate cancer have a low risk of dying early, those with advanced forms of cancer do not live as long as older men with similar forms of the disease. READ MORE>
May 23: PROSTABLOG NZ: Book review: An an excellent new book on prostate cancer has just published by the Michael Dattoli and his colleagues in Florida – The Dattoli Blue Ribbon Prostate Cancer Solution: How to survive and thrive without surgery (February, 2009). READ MORE>
MAY 22: TV3: A federally funded US study has found that people who started taking ginger capsules several days before a chemotherapy infusion had fewer and less severe bouts of nausea afterward than others who were given dummy capsules. READ MORE>
MAY 21: NEW PROSTATE CANCER INFO-LINK: Comment on this week’s reports of a UK “three-minute” prostate cancer risk test: “This research, it should be noted, is in a very early stage,” says Mike Scott. “It would need to be extensively validated before we can be sure that this is the case.” READ MORE>
MAY 21: NEW PROSTATE CANCER INFO-LINK: Men presenting with PSA values of 2.0-3.0 ng/ml should be re-examined more frequently, and that available nomograms should be used specifically to determine risk and the need for biopsy in this category of men, say researchers using data from the European Randomized Study of Screening for Prostate Cancer. READ MORE>
MAY 21: MEDICAL COLLEGE OF GEORGIA: A protein that helps regulate expression of androgen receptors could prove a new focal point for staging and treating testosterone-fuelled prostate cancer, say Medical College of Georgia researchers. Levels of the protein, βarrestin2, are lower in some prostate cancer cells than in normal prostate cells while expression of testosterone-fed androgen receptors is higher, they report in Proceedings of the National Academy of Sciences Online Early Edition this week. READ MORE>
MAY 21: CANCER CONSULTANTS.COM: Among men treated with radical prostatectomy and found to have pT3 prostate cancer (cancer that extends beyond the prostate capsule), adjuvant (followup) treatment with radiation therapy reduces the risk of post-treatment PSA increase, according to the results of a Phase III clinical trial published in the Journal of Clinical Oncology. READ MORE>
MAY 21: NCI CANCER BULLETIN: Many cases of prostate cancer progress so slowly that it can literally take decades to learn whether a treatment works, says ask Dr Ian Thompson, who chairs the department of urology at the University of Texas Health Science Center at San Antonio. READ MORE>
MAY 21: URO TODAY: Most of the men treated with brachytherapy and observed in a new study conserved ejaculatory function after treatment, but also experienced a reduction in volume and deterioration in orgasm. READ MORE>
MAY 21: PROSTABLOG NZ: The Kiwi rowing team, Rowing For Prostate, is close to second place again in the Indian Ocean Rowing Race, just three miles behind the women’s four, Pura Vida. READ MORE>
MAY 20: BBC: A three-minute test for prostate cancer is being developed by scientists. The test works by shining a light through a semen sample to determine levels of a molecule called citrate, which dip in cancer’s early stages. READ MORE>
MAY 20: IRISH TIMES: It stands to reason that foods with natural antioxidant and anti-inflammatory properties might have a protective role against the development of prostate cancer. Numerous studies have been done (and there are ongoing studies) to investigate the role nutrition plays in the prevention and even the treatment of prostate cancer. It is very difficult to say categorically whether any one substance is helpful in decreasing the risk of developing the disease. READ MORE>
MAY 20: NEW YORK TIMES: Personal story: I learned I had prostate cancer in April 2008. And this time there has been none of the naïveté of the 12-year-old, nor the heedlessness of the 27-year-old. When you’re 50, even if you don’t have cancer, mortality is not an abstraction. READ MORE>
MAY 20: URO TODAY: The US Preventive Services Task Force recently strengthened its recommendation against screening men over 75 years old. To date, however, screening among older patients remains common, and does not adequately reflect patient life expectancy. READ MORE>
MAY 19: UNIVERSITY OF CINCINNATI: University of Cincinnati cancer and cell biologists have identified a new molecular pathway key to the development of invasive prostate cancers. The UC team found in a study that simultaneous inactivation of two particular genes—known as PTEN and Par-4—caused the rapid development of invasive prostate cancer tumors in mice. READ MORE>
MAY 19: DOCTOR’S GUIDE.COM: Bone mineral density significantly increased for prostate cancer patients treated with androgen ablation therapy if their doctors followed guidelines published in 2004, according to study results presented at the American Association of Clinical Endocrinologists annual meeting in Houston, Texas. READ MORE>
MAY 19: URO TODAY: Patients with locally advanced prostate cancer have a high risk of progression after radical prostatectomy as single therapy, a Swedish study has found. Post-operative radio therapy has been shown to improve the outcome. Neoadjuvant/adjuvant hormonal therapy has been shown to improve the outcome after RT. Bringing this knowledge together offering a multi-modality therapy with neoadjuvant/adjuvant hormonal therapy, RP followed by post-operative immediate RT seems to offer a high chance of biochemical-free survival. READ MORE>
MAY 19: PROSTABLOG NZ: The northerly route they chose seems to have paid off for Indian Ocean Rowing Race leaders Bexhill Trust, who have moved ahead by 40 miles, despite recording the lowest mileage of all four leading crews in the last 24 hours.
MAY 19: PROSTABLOG NZ: Someone’s making a lot of money from prostate cancer sufferers, as a report analysing world-wide markets for prostate cancer therapeutics (mostly hormonal therapies) – including 138 companies – shows. READ MORE>
MAY 18: PROSTABLOG NZ: With halfway approaching slowly, the leading three boats have closed to within 60 miles of each other in the Indian Ocean Rowing Race, with the Kiwi boat making good ground. READ MORE>
MAY 18: NATURAL NEWS: A new study in the Journal of the National Cancer Institute adds more evidence to the increasingly prevalent belief that regular prostate screenings may lead to more harm than good for older men. READ MORE>
MAY 18: NEW PROSTATE CANCER INFO-LINK: Additional papers about prostate cancer treatment are being delivered to the upcoming American Society for Clinical Oncology conference: READ HERE>
MAY 18: BUSINESS ETHICS & PRACTICE: Based on a small study, US researchers say that comprehensive lifestyle changes, including a better diet and more exercise, can quickly cause dramatic changes at the genetic level. As expected, they lost weight, lowered their blood pressure and saw other health improvements. But the “before” and “after” prostate biopsies were startling. READ MORE>
MAY 17: MEDSCAPE TODAY: Is there a mortality benefit with regard to prostate cancer from regular prostate-specific antigen (PSA) testing and digital rectal examination (DRE)? The answer is unclear, says this VIDEO on Medscape Today
MAY 16: NEW PROSTATE CANCER INFO-LINK: Researchers have developed of an implantable sensor which, they claim, could offer continuous cancer monitoring and obviate the need for invasive post-treatment monitoring methods. READ MORE>
MAY 16: NEW PROSTATE CANCER INFO-LINK: A paper published recently in Supportive Care in Cancer addresses the diagnosis of prostate cancer as a biographically disruptive event for men. It profoundly changes many of their lives in unexpected ways. READ MORE>
MAY 16: NEW PROSTATE CANCER INFO-LINK: The results of at least 15 prostate cancer-related studies will be presented at the upcoming annual meeting of the American Society for Clinical Oncology in Orlando, Florida, at the end of May. READ MORE>
MAY 16: DRUGS.COM: Researchers claim to have found a way to better customise the treatment of prostate cancer. Four risk factors that can help predict how long men could survive with metastatic prostate cancer have been identified by researchers from the Duke Comprehensive Cancer Center, who say such information would help doctors individualise treatments. READ MORE>
MAY 16: SF WEEKLY.COM: Previous studies linking heart-nourishing omega-3 fatty acids with prostate cancer have been discredited in a study just published in the American Journal of Clinical Nutrition. READ MORE> and HERE>
MAY 16, BIO-MEDICINE: Cancer researchers have discovered that low-oxygen regions in prostate tumours can be used to predict a rise in PSA levels, a marker of tumour recurrence in prostate cancer. The long-term study results will be presented at the 2009 American Society of Clinical Oncology annual meeting in Orlando, Florida, soon. READ MORE>
MAY 16: PROSTABLOG NZ: It may take “some weeks” before NZ’s new Minister of Health, Tony Ryall, can respond to the question: what’s happened to prostate cancer as a key government health priority? READ MORE>
MAY 15: US NATIONAL CANCER INSTITUTE BULLETIN: The number of US cancer cases is expected to increase dramatically over the next two decades – particularly among older adults and minorities – but prostate cancer is not among the fastest risers. READ MORE>
MAY 15: WALL STREET JOURNAL: Summaries of more than 4000 cancer studies – including several notable ones – will be released this week, two weeks before a key, closely watched medical conference begins. READ MORE>
MAY 15: SCIENCE DAILY: A ground-breaking Canada-wide clinical trial has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients, including prostate. The study demonstrates that ribavirin suppresses the activities of the eIF4E gene in patients. This gene is dysregulated in 30 percent of cancers including breast, prostate, head and neck, colon and stomach cancer. READ MORE>
MAY 15: INDYSTAR.COM: A cancer care centre in Indiana, US, has just set up the Calypso positioning system to enhance accuracy when using external radiation on a prostate tumour. READ MORE>
MAY 15: SOUTHERN STAR, IRELAND: Prostate cancer in Irish men will show a 275% increase by 2020, says the latest data from the National Cancer Registry of Ireland. By that year, 3768 new cases will be diagnosed, compared with 2536 new cases in 2007. The current rate is similar to NZ’s. READ MORE>
MAY 15: PROSTABLOG NZ: Four of the seven boats have now crossed the 1000-mile mark in the Indian Ocean Rowing Race and race leaders Pura Vida are now fast approaching half way. READ MORE>
MAY 15: PROSTABLOG NZ: A growing group of scientific heretics – published in highly respected medical journals, working at some of the most august institutions – strongly believe that it’s time to rethink our whole approach to cancer screening, says the Reader’s Digest article that’s drawn a furious reaction from the American Cancer Society. READ MORE>
MAY 14: MARKET WATCH: The latest science-based guidelines on nutrition and exercise as they relate to prostate health and cancer prevention are now available in a new publication from the US Prostate Cancer Foundation. The guide, Nutrition, Exercise and Prostate Cancer, is available in electronic form on the foundation’s website, www.pcf.org. Individuals can also order a printed copy of the booklet online. READ MORE>
MAY 14: READERS DIGEST: Things are getting heated in the US prostate screening debate: see the full text of an angry letter from the American Cancer Society sent to Reader’s Digest following an article it ran on prostate cancer screening in April. READ MORE>
MAY 14: MACON.COM: The first wireless, implantable sensor approved for use in the treatment of breast and prostate cancer is taking the guesswork — and some of the sting — out of radiation treatments. In February, the Coliseum Medical Centers began offering the Dose Verification System, or DVS. The sensors are 2.1 millimeters in diameter and 20 millimeters long, and once implanted can gather and transmit data on the precise amount of radiation being delivered to patients. READ MORE>
MAY 14: THE HINDU:People in cities are more likely to develop late-stage cancer than those living in suburban and rural areas, a study of people living in Illinois, US, has found. A high concentration of vulnerable populations and economically disadvantaged areas in Chicago and its suburbs accounted for the high rates of late-stage diagnosis found in these highly urban areas. READ MORE>
MAY 14: MEMPHIS DAILY NEWS: Memphis company GTx expects to receive approval from the US Food and Drug Administration on Octopber 30 to begin selling a drug to prevent bone fractures in men undergoing hormone therapy to treat bone cancer. The company also has other drugs in the pipeline related to the prevention and treatment of prostate cancer and to build body mass in people with cancer-induced muscle loss. READ MORE>
MAY 14: FORBES: A US drug development company in the final stage of trialling a drug for prostate cancer patients who have failed chemotherapy has reported a loss of $23.3 million and no revenue. Los Angeles-based Cougar Biotechnology Inc is also conducting a late-stage study of the drug for prostate cancer patients who have not yet had chemotherapy. READ MORE>
MAY 14: JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION: A diet and exercise regime reduced the rate of self-reported functional decline (compared with no intervention) among older, long-term survivors of colorectal, breast, and prostate cancer, says a new US report. READ MORE>
MAY 14: NEW PROSTATE CANCER INFO-LINK: Men with advanced prostate cancer who received androgen deprivation therapy using Luteinizing hormone-releasing hormone agonist showed significant and sustained decreases in bone mineral density, compared with those on anti-androgen therapy with bicalutamide, according to a UK study of 618 patients. READ MORE>
MAY 14: NEW PROSTATE CANCER INFO-LINK: There is currently insufficient evidence to support population-based screening programmes, says a new Japanese study. PSA and DRE [are] not recommended for population-based screening programs, but they could be conducted as individual-based screening if basic requirements were met. READ MORE>
MAY 14: NEW PROSTATE CANCER INFO-LINK: Prostate cancer molecules flushed out in urine may be a way to assess the aggression risk of the cancer, says a BBC report. However, this is very clearly a case in which a theoretical possibility would still need enormous work before such methods could be used with accuracy to predict risk in a clinical setting. READ MORE> and HERE>
MAY 14: PROSTABLOG NZ: Kiwi-registered rowing four Rowing For Prostate remains eck-and-neck with Bexhill Trust in a fight for second in the Indian Ocean Rowing Race, both of them 100 miles behind the women’s four, Pura Vida. READ MORE>
MAY 13: BLOOMBERG: A third of men and a quarter of women undergoing cancer screening will get false positive results by the time they have undergone four tests, which can lead to inappropriate medical procedures, a study found. READ MORE> and analysis HERE>
MAY 13: SCIENCECENTRIC.COM: For men younger than 50 with prostate cancer, undergoing a radical prostatectomy can greatly increase their chances for long-term survival, according to a new study from Henry Ford Hospital. READ MORE>
MAY 13: NEW PROSTATE CANCER INFO-LINK: Older Japanese prostate patients undergoing radical perineal prostatectomy that spared nerves were not greatly concerned about a decrease in their sexual-function-related quality of life, a study of 194 people found. READ MORE>
MAY 13: NEW PROSTATE CANCER INFO-LINK: Combining gene expression data with clinical data can achieve 95% accuracy in diagnosing the seriousness of prostate cancer, a new study has found: but it’s early days yet. READ MORE>
MAY 13: UNIVERSITY OF CALIFORNIA: Alpha-linolenic acid (ALA), an omega-3 fatty acid found in plants, appears unlikely to be a cause of prostate cancer, contrary to some previous findings, according to a research review and meta-analysis by investigators at the San Francisco VA Medical Center and the University of California, San Francisco. READ MORE>
MAY 13: PROSTABLOG NZ: Nothing like a bit of skiting: but hey, this is the 200th post on Prostablog, and yesterday we had 158 hits, 38 more than the previous best. READ MORE>
MAY 12: DRUGS.COM: Three molecules associated with prostate cancer might provide the long-sought markers that could discern which tumours are life-threatening and need aggressive treatment, a new study indicates. READ MORE> However, Mike Scott at New Prostate Cancer Info-Link warns it’s relatively easy to identify biomarkers associated with early stage or progressive prostate cancer, but “much, much harder to show definitively that the presence or absence of such biomarkers is a clearly prognostic factor for a specific clinical or biological event in the development or the progression prostate cancer from the first cell to the presence of castration-resistant disease.” READ MORE>
MAY 12: McLEANS.CA: Canada has set up regional committee to have another look at prostate cancer screening using PSA tests. A number of provincial committees have been established recently to further investigate the best recommendations for prostate cancer screening, says Dr Neil E. Fleshner, head of urology at Princess Margaret Hospital in Toronto. READ MORE>
MAY 12: HEALTH BLOG: Men can’t spread prostate cancer to women, experts say – but women have a form of residual prostate gland and there are rare cases of it becoming cancerous. READ MORE>
MAY 11: NEW PROSTATE CANCER INFO-LINK: More work is needed to prove individual biomarkers are accurate indicators of aggression in prostate tumours, despite the promise of recent research findings. READ MORE>
MAY 11: XCONOMY, BOSTON: A US drug developer says it has landed $22 million in private equity financing to advance a new drug for prostate cancer that is unable to be treated with standard testosterone-blocking therapies. READ MORE>
MAY 11: NEW PROSTATE CANCER INFO-LINK: Researchers have tested a vaccine that could provide a safe and effective means to induce immune control of prostate cancer. Although there is a long way to go in developing an actual immunotherapeutic agent or agents based on this type of science, it is now increasingly clear that immunobiology holds the potential to significantly modify the course of disease in men with prostate cancer. READ MORE>
MAY 11: NEW PROSTATE CANCER INFO-LINK: Researchers have proved that high levels of vitamin A in the blood help prevent prostate cancer, but the problem is getting the levels up. READ MORE>
May 2: PROSTABLOG NZ: Does the world now have a new prostate pin-up boy, a new hero? Well, anti-hero, actually. READ MORE>
May 1: NEW PROSTATE CANCER INFO-LINK: There is still no “level 1″ evidence to support nutrition and lifestyle interventions for prevention or treatment of prostate cancer (ie, no compelling data from large, randomized, controlled clinical trials), the American Urological Association heard this week. READ MORE>
May 1, NEW PROSTATE CANCER INFO-LINK: Results of a 14-year US study of 453 men with low-risk prostate symtoms has shown “active surveillance” – with selective, delayed intervention based on well-defined criteria of risk reclassification – results in very few prostate cancer deaths. From 2000, the cohort was restricted to men with exclusively low risk disease, ie, screen-diagnosed patients with no symptoms, Gleason score ≤ 6, and PSA ≤ 10 ng/ml). Patients were all closely followed with serial PSA tests and periodic biopsies. READ MORE>
May 1: HEALTH NEWS REVIEW.ORG: Comments on AP story from the American Urological Association annual meeting on April 27 – Number needed to treat given, but cost analysis was not. 71 men x 365 days/yr. x 7 yrs. x $3/pill = $544,215 to prevent a single case of prostate cancer!! Why doesn’t that info make it into the story?.. READ MORE>
May 1: MED-SCAPE TODAY: Androgen-deprivation therapy (ADT) is a common treatment for men with prostate cancer, but patients who undergo this therapy are at an increased risk for skeletal fracture, incident diabetes, and cardiovascular-related mortality. READ MORE>
May 1: MEDILL REPORTS, CHICAGO: A blue ribbon pinned to a lapel marks the fight stepped up this week against prostate cancer. An international initiative launched in Chicago builds on the success of pink ribbon campaigns to escalate awareness about breast cancer screening and treatment. READ MORE>
May 1: BELLEVILLE NEWS-DEMOCRAT, ILLINOIS: Dutasteride has the potential to offer many thousands of men a way to reduce their risk of being diagnosed with prostate cancer. READ MORE>
May 1: PROSTABLOG NZ: The four UK women rowing for breast cancer have put in a big 24-hour effort in the Indian Ocean Rowing Race to cover 64 miles and grab the lead. READ MORE>
May 1: HUFFINGTON POST, US: There is considerable evidence that certain kinds of diet can have significant anti-cancer properties and effects:…And then there is the data on specific foods: cruciferous vegetables (broccoli, cauliflower, cabbage, etc.) have significant, repeatedly observed anticancer effects; tomatoes may help prevent prostate cancer;… READ MORE> and HERE>
Prostablog 
Leave a Reply